Allergy 0 7 0 7 O
or 8 10 8 10 O
known 11 16 11 16 O
hypersensitivity 17 33 17 33 O
for 34 37 34 37 O
AFREZZA 38 45 38 45 B-allergy_name
or 46 48 46 48 O
to 49 51 49 51 O
drugs 52 57 52 57 B-allergy_name
with 58 62 58 62 I-allergy_name
similar 63 70 63 70 I-allergy_name
chemical 71 79 71 79 I-allergy_name
structure 80 89 80 89 I-allergy_name

Any 0 3 90 93 O
concurrent 4 14 94 104 O
medical 15 22 105 112 O
or 23 25 113 115 O
major 26 31 116 121 B-chronic_disease
psychiatric 32 43 122 133 I-chronic_disease
condition 44 53 134 143 I-chronic_disease
that 54 58 144 148 O
makes 59 64 149 154 O
the 65 68 155 158 O
subject 69 76 159 166 O
unsuitable 77 87 167 177 O
for 88 91 178 181 O
the 92 95 182 185 O
clinical 96 104 186 194 B-treatment
study 105 110 195 200 I-treatment
or 111 113 201 203 O
impairs 114 121 204 211 O
the 122 125 212 215 O
subject 126 133 216 223 O
's 133 135 223 225 O
ability 136 143 226 233 O
to 144 146 234 236 O
participate 147 158 237 248 O
in 159 161 249 251 O
the 162 165 252 255 O
study 166 171 256 261 O

Any 0 3 262 265 O
disease 4 11 266 273 O
or 12 14 274 276 O
exposure 15 23 277 285 O
to 24 26 286 288 O
any 27 30 289 292 O
medication 31 41 293 303 B-treatment
which 42 47 304 309 O
, 47 48 309 310 O
in 49 51 311 313 O
the 52 55 314 317 O
judgment 56 64 318 326 O
of 65 67 327 329 O
the 68 71 330 333 O
principal 72 81 334 343 O
Investigator 82 94 344 356 O
, 94 95 356 357 O
may 96 99 358 361 O
impact 100 106 362 368 O
glucose 107 114 369 376 O
metabolism 115 125 377 387 O

Body 0 4 388 392 B-bmi
mass 5 9 393 397 I-bmi
index 10 15 398 403 I-bmi
below 16 21 404 409 O
25th 22 26 410 414 B-upper_bound
or 27 29 415 417 O
above 30 35 418 423 O
95th 36 40 424 428 B-lower_bound
percentile 41 51 429 439 O
for 52 55 440 443 O
age 56 59 444 447 B-age
and 60 63 448 451 O
gender 64 70 452 458 O
according 71 80 459 468 O
to 81 83 469 471 O
Centers 84 91 472 479 O
for 92 95 480 483 O
Disease 96 103 484 491 O
Control 104 111 492 499 O
and 112 115 500 503 O
Prevention 116 126 504 514 O
growth 127 133 515 521 O
charts 134 140 522 528 O

Children 0 8 529 537 O
aged 9 13 538 542 B-age
≥4 14 16 543 545 O
and 17 20 546 549 O
≤17 21 24 550 553 O
years 25 30 554 559 I-upper_bound
( 31 32 560 561 O
enrolled 32 40 561 569 O
sequentially 41 53 570 582 O
into 54 58 583 587 O
3 59 60 588 589 O
age 61 64 590 593 O
cohorts 65 72 594 601 O
: 72 73 601 602 O
13 74 76 603 605 B-lower_bound
to 77 79 606 608 O
17 80 82 609 611 O
, 82 83 611 612 O
8 84 85 613 614 B-lower_bound
to 86 88 615 617 O
12 89 91 618 620 B-upper_bound
, 91 92 620 621 O
and 93 96 622 625 O
4 97 98 626 627 O
to 99 101 628 630 O
7 102 103 631 632 O
years 104 109 633 638 O
) 109 110 638 639 O

Clinical 0 8 640 648 O
diagnosis 9 18 649 658 O
of 19 21 659 661 O
T1DM 22 26 662 666 B-chronic_disease
and 27 30 667 670 O
using 31 36 671 676 O
insulin 37 44 677 684 B-treatment
for 45 48 685 688 O
at 49 51 689 691 O
least 52 57 692 697 O
1 58 59 698 699 B-lower_bound
year 60 64 700 704 I-lower_bound

Currently 0 9 705 714 O
receiving 10 19 715 724 O
a 20 21 725 726 O
regimen 22 29 727 734 B-treatment
of 30 32 735 737 I-treatment
basal 33 38 738 743 I-treatment
/ 38 39 743 744 I-treatment
bolus 39 44 744 749 I-treatment
insulin 45 52 750 757 I-treatment
administered 53 65 758 770 O
by 66 68 771 773 O
MDI 69 72 774 777 O
for 73 76 778 781 O
at 77 79 782 784 O
least 80 85 785 790 O
6 86 87 791 792 B-lower_bound
weeks 88 93 793 798 I-lower_bound
prior 94 99 799 804 I-lower_bound
to 100 102 805 807 O
enrollment 103 113 808 818 O

Evidence 0 8 819 827 O
of 9 11 828 830 O
any 12 15 831 834 O
complication 16 28 835 847 O
of 29 31 848 850 O
diabetes 32 40 851 859 B-chronic_disease
( 41 42 860 861 O
proliferative 42 55 861 874 B-chronic_disease
retinopathy 56 67 875 886 I-chronic_disease
, 67 68 886 887 O
autonomic 69 78 888 897 B-chronic_disease
neuropathy 79 89 898 908 I-chronic_disease
, 89 90 908 909 O
nephropathy 91 102 910 921 B-chronic_disease
, 102 103 921 922 O
etc 104 107 923 926 O
) 107 108 926 927 O
, 108 109 927 928 O
or 110 112 929 931 O
likelihood 113 123 932 942 O
of 124 126 943 945 O
requiring 127 136 946 955 O
laser 137 142 956 961 B-treatment
photocoagulation 143 159 962 978 I-treatment
, 159 160 978 979 O
vitrectomy 161 171 980 990 B-treatment
, 171 172 990 991 O
or 173 175 992 994 O
other 176 181 995 1000 O
specific 182 190 1001 1009 B-treatment
treatment 191 200 1010 1019 I-treatment
for 201 204 1020 1023 O
diabetic 205 213 1024 1032 B-chronic_disease
retinopathy 214 225 1033 1044 I-chronic_disease
in 226 228 1045 1047 O
the 229 232 1048 1051 O
coming 233 239 1052 1058 O
year 240 244 1059 1063 O

Exposure 0 8 1064 1072 O
to 9 11 1073 1075 O
any 12 15 1076 1079 O
investigational 16 31 1080 1095 B-treatment
product(s 32 41 1096 1105 I-treatment
) 41 42 1105 1106 I-treatment
in 43 45 1107 1109 O
the 46 49 1110 1113 O
past 50 54 1114 1118 B-upper_bound
3 55 56 1119 1120 I-upper_bound
months 57 63 1121 1127 I-upper_bound
or 64 66 1128 1130 O
5 67 68 1131 1132 O
half 69 73 1133 1137 O
- 73 74 1137 1138 O
lives 74 79 1138 1143 O
, 79 80 1143 1144 O
whichever 81 90 1145 1154 O
is 91 93 1155 1157 O
more 94 98 1158 1162 O

Fasting 0 7 1163 1170 B-clinical_variable
serum 8 13 1171 1176 I-clinical_variable
C 14 15 1177 1178 I-clinical_variable
- 15 16 1178 1179 I-clinical_variable
peptide 16 23 1179 1186 I-clinical_variable
≤0.3 24 28 1187 1191 O
ng 29 31 1192 1194 I-upper_bound
/ 31 32 1194 1195 I-upper_bound
mL 32 34 1195 1197 I-upper_bound

Females 0 7 1198 1205 B-gender
of 8 10 1206 1208 O
childbearing 11 23 1209 1221 O
potential 24 33 1222 1231 O
, 33 34 1231 1232 O
must 35 39 1233 1237 O
use 40 43 1238 1241 B-contraception_consent
highly 44 50 1242 1248 I-contraception_consent
effective 51 60 1249 1258 I-contraception_consent
methods 61 68 1259 1266 I-contraception_consent
of 69 71 1267 1269 I-contraception_consent
contraception 72 85 1270 1283 I-contraception_consent
throughout 86 96 1284 1294 O
conduct 97 104 1295 1302 O
of 105 107 1303 1305 O
the 108 111 1306 1309 O
trial 112 117 1310 1315 O

Forced 0 6 1316 1322 B-clinical_variable
expiratory 7 17 1323 1333 I-clinical_variable
volume 18 24 1334 1340 I-clinical_variable
in 25 27 1341 1343 I-clinical_variable
1 28 29 1344 1345 I-clinical_variable
second 30 36 1346 1352 I-clinical_variable
( 37 38 1353 1354 I-clinical_variable
FEV1 38 42 1354 1358 I-clinical_variable
) 42 43 1358 1359 I-clinical_variable
≥70 44 47 1360 1363 O
% 47 48 1363 1364 I-lower_bound
of 49 51 1365 1367 O
National 52 60 1368 1376 O
Health 61 67 1377 1383 O
and 68 71 1384 1387 O
Nutrition 72 81 1388 1397 O
Examination 82 93 1398 1409 O
Survey 94 100 1410 1416 O
( 101 102 1417 1418 O
NHANES 102 108 1418 1424 O
) 108 109 1424 1425 O
III 110 113 1426 1429 O
predicted 114 123 1430 1439 O
for 124 127 1440 1443 O
children 128 136 1444 1452 O
≥8 137 139 1453 1455 O
years 140 145 1456 1461 O
of 146 148 1462 1464 O
age 149 152 1465 1468 B-age
or 153 155 1469 1471 O
Wang 156 160 1472 1476 O
predicted 161 170 1477 1486 O
for 171 174 1487 1490 O
children 175 183 1491 1499 O
< 184 185 1500 1501 O
8 185 186 1501 1502 O
years 187 192 1503 1508 O
of 193 195 1509 1511 O
age 196 199 1512 1515 O

Forced 0 6 1516 1522 B-clinical_variable
vital 7 12 1523 1528 I-clinical_variable
capacity 13 21 1529 1537 I-clinical_variable
≥70 22 25 1538 1541 O
% 25 26 1541 1542 I-lower_bound
of 27 29 1543 1545 O
NHANES 30 36 1546 1552 B-clinical_variable
III 37 40 1553 1556 I-clinical_variable
predicted 41 50 1557 1566 I-clinical_variable
for 51 54 1567 1570 I-clinical_variable
children 55 63 1571 1579 I-clinical_variable
≥8 64 66 1580 1582 O
years 67 72 1583 1588 O
of 73 75 1589 1591 O
age 76 79 1592 1595 B-age
or 80 82 1596 1598 O
Wang 83 87 1599 1603 B-clinical_variable
predicted 88 97 1604 1613 I-clinical_variable
for 98 101 1614 1617 I-clinical_variable
children 102 110 1618 1626 I-clinical_variable
< 111 112 1627 1628 O
8 112 113 1628 1629 O
years 114 119 1630 1635 O
of 120 122 1636 1638 O
age 123 126 1639 1642 O

Hemoglobin 0 10 1643 1653 B-clinical_variable
A1c 11 14 1654 1657 I-clinical_variable
( 15 16 1658 1659 I-clinical_variable
HbA1c 16 21 1659 1664 I-clinical_variable
) 21 22 1664 1665 I-clinical_variable
≥7.0 23 27 1666 1670 O
% 27 28 1670 1671 I-lower_bound
to 29 31 1672 1674 O
< 32 33 1675 1676 O
10.0 33 37 1676 1680 B-upper_bound
% 37 38 1680 1681 I-upper_bound
at 39 41 1682 1684 O
the 42 45 1685 1688 O
time 46 50 1689 1693 O
of 51 53 1694 1696 O
screening 54 63 1697 1706 O

History 0 7 1707 1714 O
of 8 10 1715 1717 O
eating 11 17 1718 1724 B-chronic_disease
disorder 18 26 1725 1733 I-chronic_disease

History 0 7 1734 1741 O
of 8 10 1742 1744 O
physician 11 20 1745 1754 O
diagnosis 21 30 1755 1764 O
of 31 33 1765 1767 O
asthma 34 40 1768 1774 B-chronic_disease
or 41 43 1775 1777 O
any 44 47 1778 1781 O
other 48 53 1782 1787 O
clinically 54 64 1788 1798 O
important 65 74 1799 1808 O
pulmonary 75 84 1809 1818 B-chronic_disease
disease 85 92 1819 1826 I-chronic_disease
, 92 93 1826 1827 O
or 94 96 1828 1830 O
use 97 100 1831 1834 O
of 101 103 1835 1837 O
any 104 107 1838 1841 O
medications 108 119 1842 1853 B-treatment
to 120 122 1854 1856 O
treat 123 128 1857 1862 O
such 129 133 1863 1867 O
conditions 134 144 1868 1878 O
within 145 151 1879 1885 O
the 152 155 1886 1889 O
last 156 160 1890 1894 O
year 161 165 1895 1899 O

Positive 0 8 1900 1908 B-pregnancy
urine 9 14 1909 1914 I-pregnancy
pregnancy 15 24 1915 1924 I-pregnancy
test 25 29 1925 1929 O
for 30 33 1930 1933 O
female 34 40 1934 1940 B-gender
subjects 41 49 1941 1949 I-gender
of 50 52 1950 1952 O
childbearing 53 65 1953 1965 O
potential 66 75 1966 1975 O

Respiratory 0 11 1976 1987 B-chronic_disease
tract 12 17 1988 1993 I-chronic_disease
infection 18 27 1994 2003 I-chronic_disease
within 28 34 2004 2010 O
30 35 37 2011 2013 B-upper_bound
days 38 42 2014 2018 I-upper_bound
before 43 49 2019 2025 I-upper_bound
screening 50 59 2026 2035 O
or 60 62 2036 2038 O
between 63 70 2039 2046 O
screening 71 80 2047 2056 O
and 81 84 2057 2060 O
initiation 85 95 2061 2071 O
of 96 98 2072 2074 O
treatment 99 108 2075 2084 B-treatment
period 109 115 2085 2091 O
; 115 116 2091 2092 O
subject 117 124 2093 2100 O
may 125 128 2101 2104 O
return 129 135 2105 2111 O
4 136 137 2112 2113 B-upper_bound
weeks 138 143 2114 2119 I-upper_bound
after 144 149 2120 2125 I-upper_bound
resolution 150 160 2126 2136 O
of 161 163 2137 2139 O
the 164 167 2140 2143 O
infection 168 177 2144 2153 O
for 178 181 2154 2157 O
rescreening 182 193 2158 2169 O

Serum 0 5 2170 2175 B-clinical_variable
creatinine 6 16 2176 2186 I-clinical_variable
≥ 17 18 2187 2188 O
the 19 22 2189 2192 O
upper 23 28 2193 2198 O
limit 29 34 2199 2204 O
of 35 37 2205 2207 O
normal 38 44 2208 2214 O
for 45 48 2215 2218 O
age 49 52 2219 2222 B-age

Smoking 0 7 2223 2230 O
of 8 10 2231 2233 O
tobacco 11 18 2234 2241 O
or 19 21 2242 2244 O
other 22 27 2245 2250 O
substances 28 38 2251 2261 O
or 39 41 2262 2264 O
positive 42 50 2265 2273 O
urine 51 56 2274 2279 B-clinical_variable
cotinine 57 65 2280 2288 I-clinical_variable
testing 66 73 2289 2296 I-clinical_variable
( 74 75 2297 2298 O
> 75 76 2298 2299 O
100 76 79 2299 2302 B-lower_bound
ng 80 82 2303 2305 I-lower_bound
/ 82 83 2305 2306 I-lower_bound
mL 83 85 2306 2308 I-lower_bound
) 85 86 2308 2309 O

Subjects 0 8 2310 2318 O
on 9 11 2319 2321 O
a 12 13 2322 2323 O
regimen 14 21 2324 2331 O
of 22 24 2332 2334 O
insulin 25 32 2335 2342 O
via 33 36 2343 2346 O
continuous 37 47 2347 2357 O
SC 48 50 2358 2360 O
insulin 51 58 2361 2368 O
infusion 59 67 2369 2377 O
may 68 71 2378 2381 O
be 72 74 2382 2384 O
enrolled 75 83 2385 2393 O
if 84 86 2394 2396 O
they 87 91 2397 2401 O
satisfy 92 99 2402 2409 O
all 100 103 2410 2413 O
other 104 109 2414 2419 O
enrollment 110 120 2420 2430 O
criteria 121 129 2431 2439 O
and 130 133 2440 2443 O
are 134 137 2444 2447 O
willing 138 145 2448 2455 O
to 146 148 2456 2458 O
convert 149 156 2459 2466 O
to 157 159 2467 2469 O
MDI 160 163 2470 2473 B-treatment
for 164 167 2474 2477 O
the 168 171 2478 2481 O
duration 172 180 2482 2490 O
of 181 183 2491 2493 O
the 184 187 2494 2497 O
study 188 193 2498 2503 O
, 193 194 2503 2504 O
beginning 195 204 2505 2514 O
6 205 206 2515 2516 B-upper_bound
weeks 207 212 2517 2522 I-upper_bound
prior 213 218 2523 2528 I-upper_bound
to 219 221 2529 2531 O
enrollment 222 232 2532 2542 O
. 232 233 2542 2543 O
They 234 238 2544 2548 O
must 239 243 2549 2553 O
continue 244 252 2554 2562 O
to 253 255 2563 2565 O
meet 256 260 2566 2570 O
all 261 264 2571 2574 O
enrollment 265 275 2575 2585 O
criteria 276 284 2586 2594 O
after 285 290 2595 2600 O
converting 291 301 2601 2611 O
to 302 304 2612 2614 O
the 305 308 2615 2618 O
MDI 309 312 2619 2622 B-treatment
regimen 313 320 2623 2630 I-treatment

Subjects 0 8 2631 2639 O
with 9 13 2640 2644 O
pre 14 17 2645 2648 O
- 17 18 2648 2649 O
breakfast 18 27 2649 2658 O
self 28 32 2659 2663 O
monitored 33 42 2664 2673 O
blood 43 48 2674 2679 B-clinical_variable
glucose 49 56 2680 2687 I-clinical_variable
values 57 63 2688 2694 I-clinical_variable
between 64 71 2695 2702 O
80 72 74 2703 2705 B-lower_bound
and 75 78 2706 2709 O
250 79 82 2710 2713 B-upper_bound
mg 83 85 2714 2716 I-upper_bound
/ 85 86 2716 2717 I-upper_bound
dL 86 88 2717 2719 I-upper_bound
for 89 92 2720 2723 O
5 93 94 2724 2725 O
of 95 97 2726 2728 O
7 98 99 2729 2730 O
documented 100 110 2731 2741 O
daily 111 116 2742 2747 O
readings 117 125 2748 2756 O
obtained 126 134 2757 2765 O
in 135 137 2766 2768 O
the 138 141 2769 2772 O
week 142 146 2773 2777 O
prior 147 152 2778 2783 O
to 153 155 2784 2786 O
Visit 156 161 2787 2792 O
2 162 163 2793 2794 O
( 164 165 2795 2796 O
readings 165 173 2796 2804 O
to 174 176 2805 2807 O
be 177 179 2808 2810 O
taken 180 185 2811 2816 O
using 186 191 2817 2822 O
glucometer 192 202 2823 2833 O
provided 203 211 2834 2842 O
at 212 214 2843 2845 O
Screening 215 224 2846 2855 O
Visit 225 230 2856 2861 O
1 231 232 2862 2863 O
) 232 233 2863 2864 O
and 234 237 2865 2868 O
reported 238 246 2869 2877 O
via 247 250 2878 2881 O
the 251 254 2882 2885 O
e 255 256 2886 2887 O
Diary 257 262 2888 2893 O

Total 0 5 2894 2899 O
daily 6 11 2900 2905 O
insulin 12 19 2906 2913 B-clinical_variable
dose 20 24 2914 2918 I-clinical_variable
≤1.5 25 29 2919 2923 O
units 30 35 2924 2929 I-upper_bound
/ 35 36 2929 2930 I-upper_bound
kg 36 38 2930 2932 I-upper_bound
/ 38 39 2932 2933 I-upper_bound
day 39 42 2933 2936 I-upper_bound
with 43 47 2937 2941 O
a 48 49 2942 2943 O
minimum 50 57 2944 2951 O
of 58 60 2952 2954 O
3 61 62 2955 2956 B-lower_bound
units 63 68 2957 2962 I-lower_bound
of 69 71 2963 2965 O
RAA 72 75 2966 2969 B-clinical_variable
at 76 78 2970 2972 O
every 79 84 2973 2978 O
meal 85 89 2979 2983 O

Unstable 0 8 2984 2992 O
diabetes 9 17 2993 3001 B-chronic_disease
control 18 25 3002 3009 O
, 25 26 3009 3010 O
defined 27 34 3011 3018 O
as 35 37 3019 3021 O
2 38 39 3022 3023 B-lower_bound
or 40 42 3024 3026 O
more 43 47 3027 3031 O
episodes 48 56 3032 3040 O
of 57 59 3041 3043 O
severe 60 66 3044 3050 O
hypoglycemia 67 79 3051 3063 B-chronic_disease
( 80 81 3064 3065 O
i.e. 81 85 3065 3069 O
, 85 86 3069 3070 O
an 87 89 3071 3073 O
episode 90 97 3074 3081 O
associated 98 108 3082 3092 O
with 109 113 3093 3097 O
a 114 115 3098 3099 O
seizure 116 123 3100 3107 B-cancer
, 123 124 3107 3108 O
coma 125 129 3109 3113 B-chronic_disease
, 129 130 3113 3114 O
or 131 133 3115 3117 O
loss 134 138 3118 3122 B-chronic_disease
of 139 141 3123 3125 I-chronic_disease
consciousness 142 155 3126 3139 I-chronic_disease
) 155 156 3139 3140 O
or 157 159 3141 3143 O
any 160 163 3144 3147 O
hospitalization 164 179 3148 3163 O
or 180 182 3164 3166 O
emergency 183 192 3167 3176 O
room 193 197 3177 3181 O
visit 198 203 3182 3187 O
for 204 207 3188 3191 O
poor 208 212 3192 3196 O
diabetes 213 221 3197 3205 O
control 222 229 3206 3213 O
, 229 230 3213 3214 O
ketoacidosis 231 243 3215 3227 B-chronic_disease
, 243 244 3227 3228 O
hypoglycemia 245 257 3229 3241 O
, 257 258 3241 3242 O
or 259 261 3243 3245 O
hyperglycemia 262 275 3246 3259 B-chronic_disease
within 276 282 3260 3266 O
the 283 286 3267 3270 O
preceding 287 296 3271 3280 B-upper_bound
3 297 298 3281 3282 I-upper_bound
months 299 305 3283 3289 I-upper_bound
from 306 310 3290 3294 O
screening 311 320 3295 3304 O

